Tofacitinib
Tofacitinib is an oral inhibitor of janus kinases, which is approved for the treatment of rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis in adults; its efficacy in the treatment of psoriasis has also been demonstrated in clinical studies. A 10 mg daily dose has been observed to ac...
| Hoofdauteur: | |
|---|---|
| Formaat: | Artikel |
| Taal: | English |
| Gepubliceerd in: |
Galenos Publishing House
2022-04-01
|
| Reeks: | Turkderm Turkish Archives of Dermatology and Venereology |
| Onderwerpen: | |
| Online toegang: | https://journal.turkderm.org.tr/jvi.aspx?pdir=turkderm&plng=eng&un=TURKDERM-64715&look4= |